Info
🌱 來自: ESMO Checklist
ESMO Checklist_Gynaecologic Cancer
Past Personal Medical History and Vascular Risk Factors
Other Cancers
Family Cancer History
Gynaecological History
- Past Gyneco Surgery
- Pregnancy
- Childbirth
- Fertility Preserving Procedures
- Hormonal Therapy
Pap Test and HPV Status
- Including HPV Vaccination
Past Surgical and RT History
Concurrent Medication
Allergies
Smoking History
- <> packs/year from age <> to age <>
Alcohol Consumption
Normal Weight
- Height:
- BMI:
Present Medical Conditions (Date: <>/<>/<>)
- Main Symptoms:
- Weight Loss:
- ECOG Performance Status:
- Pain (Scale):
- Other Relevant Clinical Conditions:
Diagnosis and Clinical Staging (Date: <>/<>/<>)
- CA 125
- BRCA2/1 Status
- Nodal Staging
Imaging and Scans
- CT (Date: <>/<>/<>)
- MRI (Date: <>/<>/<>)
- PET/CT (Date: <>/<>/<>)
- Ultrasound (Date: <>/<>/<>)
- Technetium Bone Scan (Date: <>/<>/<>)
- Whole Body CT Scan (Date: <>/<>/<>)
- Abdomen MRI (Date: <>/<>/<>)
- PET/CT (Date: <>/<>/<>)
Staging for Metastases
- TNM Stage and Grade (Date: <>/<>/<>)
Histological Analysis (Date: <>/<>/<>)
- Biopsy
- Surgery: Histology, Grade, ER, HER2, MSI Status, LVSI
- Genetic Testing: BRCA2/1, HRD, p53
- pTNM Staging
- FIGO Staging
Timeline for Further Work-Up
- Checked and tight enough: YES/NO
MDT Discussion and Decision (Date: <>/<>/<>)
- Surgery
- Adjuvant Medical Therapy
- Neo-adjuvant Medical Therapy
- Chemoradiotherapy
- 1st Line of Metastatic Therapy
- 2nd Line of Metastatic Therapy
- 3rd and Later Lines of Metastatic Therapy
- Palliative ST (Bones, CNS)
- Supportive and Palliative Care
- Enrolment in a Clinical Trial
- Compassionate Use/Expanded Access Programme
Treatment Options
- Discussed with the patient and strategy accepted: YES/NO